Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash Flows from Operating Activities:
Net income	$ 3,256	$ 3,620
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	888	982
Provision for bad debts	506	(94)
Compensatory element of stock issuances	53	19
Stock issued for costs and expenses	76	110
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivables	(2,111)	(1,974)
Notes receivable	81	35
Costs and estimated earnings in excess of billings on uncompleted contracts	(860)
Inventories	22	(49)
Prepaid expenses and other current assets	284	210
Other assets	(5)	40
Increase (decrease) in operating liabilities, net:
Accounts payable	323	(58)
Other current liabilities	865	1,008
Customer deposits	(357)	60
Other liabilities	(123)	(29)
Due to related medical practices	(6)	(1)
Income tax payable		(20)
Net cash provided by operating activities	2,892	3,859
Cash Flows from Investing Activities:
Purchases of property and equipment	(26)	(182)
Cost of patents	(46)	(47)
Net cash used in investing activities	(72)	(229)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(921)	(970)
Distributions to noncontrolling interests	(1,191)	(1,295)
Repayment of notes receivable from employee stockholders	2	2
Net cash (used in) provided by financing activities	(2,110)	(2,263)
Net (Decrease) Increase in Cash and Cash Equivalents	710	1,367
Cash and Cash Equivalents - Beginning of Period	9,238	7,871
Cash and Cash Equivalents - End of Period	$ 10,662